Menu
Menu
Nexbis hits snag in TrustDefender spinoff

Nexbis hits snag in TrustDefender spinoff

Technology services company Nexbis CFOWorld said it had hit a snag in its plan to spin off its TrustDefender unit through an IPO.

The company said its broker mandate for the possible IPO of TrustDefender, also known as Symbiotic Technologies, has been terminated.

Nexbis paid $16 million for a 50.08% share in TrustDefender, which provides end-to-end security products, in a deal announced in March last year.

Nexbis said it will work with TrustDefender to explore alternative arrangements, including pursuing an IPO without an exclusive broker. Another option would be “securing further investment from other parties.”

Whichever route they take, the companies hope to have a transaction complete by May 31.

Nexbis said it has no intention of making further investments in TrustDefender.

The company also said it expects to formally execute a long-awaited Malaysian national security system agreement within 60 days.

NBS shares grew 5% during Friday's trading to $0.105.

Join the CIO Australia group on LinkedIn. The group is open to CIOs, IT Directors, COOs, CTOs and senior IT managers.

Join the newsletter!

Error: Please check your email address.

Tags ASX:NBS IPO Nexbis Spin-off TrustDefender

Show Comments
Computerworld
ARN
Techworld
CMO